IPO registrations (S-1, F-1) · Registrants
Aspreva Pharmaceuticals CORP
- SEC CIK
- 1314026 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2005-01-24, last 2005-03-01; 1 initial registration, 4 amendments
- Outcome
- Final prospectus filed 2005-03-04
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- A1
- Business address
- 1203-4464 MARKHAM STREET, Victoria, A1 V8Z 7X8
- EIN
- 98-0435540
- EDGAR entity type
- operating
Offering terms
- Proposed price range
- $13.00–$15.00 per share (F-1/A filed 2005-03-01)
- Final price
- $11.00 per share, below the range (424B4 filed 2005-03-04, an initial public offering)
- Shares sold
- 7,200,000
- Gross proceeds
- $79,200,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ASPV
- Lead underwriters
- Merrill Lynch
- Syndicate
- Lynch & Co; Pacific Growth; BofA Securities (1,530,000); Pacific Growth Equities, LLC (1,275,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: ASPREVA PHARMACEUTICALS INC EXACT (EIN (EXACT))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2005-01-24 | F-1 | F-1 (foreign registration) | Aspreva Pharmaceuticals CORP | 0000945234-05-000025 ↗ |
| 2005-02-11 | F-1/A | F-1/A (amendment) | Aspreva Pharmaceuticals CORP | 0000945234-05-000071 ↗ |
| 2005-02-15 | F-1/A | F-1/A (amendment) | Aspreva Pharmaceuticals CORP | 0000945234-05-000087 ↗ |
| 2005-02-28 | F-1/A | F-1/A (amendment) | Aspreva Pharmaceuticals CORP | 0000945234-05-000106 ↗ |
| 2005-03-01 | F-1/A | F-1/A (amendment) | Aspreva Pharmaceuticals CORP | 0000945234-05-000114 ↗ |
| 2005-03-04 | 424B4 | 424B4 (final prospectus) | Aspreva Pharmaceuticals CORP | 0000945234-05-000141 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2005-03-01 | F-1/A | registration statement | $13.00–$15.00 | 7,200,000 | - | Nasdaq ASPV | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2005-03-04 | 424B4 | final prospectus | $11.00 | 7,200,000 | $79,200,000 | Nasdaq ASPV | 5 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 4 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form 5500 plan sponsor | ASPREVA PHARMACEUTICALS INC | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, A1 first:
- ONCOGENEX TECHNOLOGIES INC A1
- Lexaria Bioscience Corp. A1
- Zymeworks BC Inc. A1
- BetterLife Pharma Inc. A1
- ABATTIS BIOCEUTICALS CORP A1
- BriaCell Therapeutics Corp. A1
- Old API Wind-down Ltd. A1
- AbCellera Biologics Inc. A1
- BODY & MIND INC. A1
- XORTX Therapeutics Inc. A1
In other datasets, the same topic (Health) in A1:
- Form D issuer: 1219014 B.C. Ltd. (Form D private offerings)
Interests: Pharmaceutical Preparations · Health